Investor Says Chiesi 'Coerced' Cornerstone Into $255M Buyout
A minority shareholder of Cornerstone Therapeutics Inc. filed a putative class action in Delaware Chancery court late Wednesday alleging Chiesi Farmaceutici SpA "coerced" the board into accepting its $255 million stock...To view the full article, register now.
Already a subscriber? Click here to view full article